Insider Transactions in Q3 2022 at Resmed Inc (RSMDF)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.33%
|
$1,293,900
$228.96 P/Share
|
|
Sep 15
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.31%
|
$323,475
$57.76 P/Share
|
|
Sep 15
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Bona fide gift
|
Indirect |
1,287
-0.56%
|
-
|
|
Sep 15
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Indirect |
6,000
-2.55%
|
$1,392,000
$232.38 P/Share
|
|
Sep 15
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Direct |
11,189
-28.26%
|
$2,595,848
$232.51 P/Share
|
|
Sep 15
2022
|
Robert Andrew Douglas Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
18,033
+17.35%
|
$1,045,914
$58.24 P/Share
|
|
Sep 06
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,545
-1.44%
|
$333,720
$216.92 P/Share
|
|
Aug 18
2022
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,847
+3.37%
|
-
|
|
Aug 18
2022
|
David Pendarvis Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,683
+1.55%
|
-
|
|
Aug 18
2022
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
BUY
Grant, award, or other acquisition
|
Direct |
3,366
+18.71%
|
-
|
|
Aug 18
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,310
+3.94%
|
-
|
|
Aug 18
2022
|
Robert Andrew Douglas Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
4,328
+16.72%
|
-
|
|
Aug 15
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.38%
|
$1,350,650
$238.09 P/Share
|
|
Aug 15
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.36%
|
$323,475
$57.76 P/Share
|
|
Aug 10
2022
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.3%
|
$600,000
$240.66 P/Share
|
|
Aug 10
2022
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.24%
|
$142,500
$57.76 P/Share
|
|
Aug 03
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,545
-1.45%
|
$370,800
$240.72 P/Share
|
|
Jul 22
2022
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-6.58%
|
$1,762,500
$235.0 P/Share
|
|
Jul 22
2022
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+2.2%
|
$427,500
$57.76 P/Share
|
|
Jul 15
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.38%
|
$1,271,200
$224.94 P/Share
|
|
Jul 15
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.36%
|
$323,475
$57.76 P/Share
|
|
Jul 05
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,545
-1.43%
|
$327,540
$212.33 P/Share
|